Elutia (ELUT) EPS (Weighted Average and Diluted) (2020 - 2026)
Elutia recorded quarterly EPS (Weighted Average and Diluted) of -$0.17 in Q1 2026, down 112.59% quarter-over-quarter from $1.35 in Q4 2025, and up 19.05% year-over-year from -$0.14 in Q1 2025.
Elutia's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$0.17 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 19.05% year-over-year to -$0.17; the TTM figure through Mar 2026 stood at $0.8 (up 137.56% YoY), while the FY2025 annual figure was $0.87, up 146.77% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.17 for Q1 2026 at Elutia, down from $1.35 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.35 in Q4 2025 to a low of -$1.14 in Q2 2024.
- A 5-year average of -$0.37 and a median of -$0.45 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) slumped 200.0% in 2022 and soared 400.0% in 2025, its largest moves.
- Elutia's EPS (Weighted Average and Diluted) stood at -$0.16 in 2022, then sank by 118.75% to -$0.35 in 2023, then dropped by 28.57% to -$0.45 in 2024, then jumped by 400.0% to $1.35 in 2025, then slumped by 112.59% to -$0.17 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.17, $1.35, and -$0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | -0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.26 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.15 |
| Sep 30, 2024 | -0.33 |
| Jun 30, 2024 | -1.13 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -0.55 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.48 |
| Mar 31, 2023 | -0.49 |
| Dec 31, 2022 | -0.36 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -0.69 |
| Mar 31, 2022 | -0.60 |
| Dec 31, 2021 | -0.84 |
| Sep 30, 2021 | -0.81 |
| Jun 30, 2021 | -0.23 |
| Mar 31, 2021 | -0.50 |
| Dec 31, 2020 | 21.94 |
| Sep 30, 2020 | -15.79 |
| Jun 30, 2020 | -7.99 |